Global Drug Device Combination Tenders and GPN from across the Globe

Alert Warfighter Enablement (Aware) Phase 0

Regulatory Services Engagement with Regulatory Authorities on Patient-Reported Outcomes (Pros)

Rfp - Intranasal Nalmefene Drug-Device Combination

Pre-Solicitation Notice: Intranasal Nalmefene Drug-Device Combination

Comparative Use Human Factors Studies to Assess the Impact of Differences between the User Interface of a Generic Drug-Device Combination Product and its Reference Listed Drug

Comparative Use Human Factors Studies to Assess the Impact of Differences between the User Interface of a Generic Drug-Device Combination Product and its Reference Listed Drug

Sources Sought Notice Intranasal Nalmefene Drug-Device Combination

2 Pam Autoinjectors

2 Pam Autoinjectors

Fda-21-Rfq-1238675 Obp Idiq for Pharmaceuticals